Pharma giant Eli Lilly acquires Washington University-founded startup Disarm Therapeutics for $135M
October 21, 2020 at 07:40 AM EDT
The company, based on the research of two of the university's scientists, is developing treatments for neurologic diseases like ALS, Parkinson's and multiple sclerosis.
